Immunocal® and Preservation of Glutathione as a Novel Neuroprotective Strategy for Degenerative Disorders of the Nervous System

Publisher： Bentham Science Publishers

E-ISSN： 2212-3954|7|3|230-235

ISSN： 1574-8898

Source： Recent Patents on CNS Drug Discovery, Vol.7, Iss.3, 2012-12, pp. : 230-235

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Application of Signal Transduction Inhibition as a Therapeutic Strategy for Central Nervous System Tumors

By  

Pediatric Neurosurgery, Vol. 29, Iss. 5, 1999-01 ,pp. : 228-244

Karger

Access to resources Recommend Favorite

The Gastrin-Releasing Peptide Receptor as a Therapeutic Target in Central Nervous System Disorders

By  

Recent Patents on CNS Drug Discovery, Vol. 2, Iss. 2, 2007-06 ,pp. : 125-129

Bentham Science Publishers

Access to resources Recommend Favorite

Phytocannabinoids and Cannabimimetic Drugs: Recent Patents in Central Nervous System Disorders

By  

Recent Patents on CNS Drug Discovery, Vol. 10, Iss. 2, 2015-08 ,pp. : 157-177

Bentham Science Publishers

Access to resources Recommend Favorite

Perilymphatic Fistula Associating with Cochleovestibular and Autonomic Nervous System Disorders

By  

Oto-Rhino-Laryngologia Nova, Vol. 8, Iss. 4, 1999-05 ,pp. : 207-210

Karger

Access to resources Recommend Favorite

Management of sexual dysfunction due to central nervous system disorders: a systematic review

By  

BJU INTERNATIONAL, Vol. 115, Iss. S6, 2015-04 ,pp. : 47-56

John Wiley & Sons Inc

Access to resources Recommend Favorite